Drug Trial News

RSS
The Lancet publishes two pirfenidone Phase 3 trial results in idiopathic pulmonary fibrosis

The Lancet publishes two pirfenidone Phase 3 trial results in idiopathic pulmonary fibrosis

CEL-SCI initiates Multikine Phase III trial for head and neck cancer in Poland

CEL-SCI initiates Multikine Phase III trial for head and neck cancer in Poland

ZIOPHARM submits IND with FDA for Ad-RTS-IL-12 Phase I study in cancer

ZIOPHARM submits IND with FDA for Ad-RTS-IL-12 Phase I study in cancer

Two DIFICID Phase 3 trial data in C. difficile infection presented at AGS Annual Meeting

Two DIFICID Phase 3 trial data in C. difficile infection presented at AGS Annual Meeting

Early antiretroviral treatment can halt HIV spread in couples

Early antiretroviral treatment can halt HIV spread in couples

Trillium raises $1 million to advance TTI-1612 into clinical trials for interstitial cystitis treatment

Trillium raises $1 million to advance TTI-1612 into clinical trials for interstitial cystitis treatment

New clinical data affirms safety profile of PolyMedix's PMX-30063 in treatment of Staph infections

New clinical data affirms safety profile of PolyMedix's PMX-30063 in treatment of Staph infections

CrystalGenomics receives draft CSR for CG400549 Phase I MAD study in Staph infections

CrystalGenomics receives draft CSR for CG400549 Phase I MAD study in Staph infections

Atox Bio completes AB103 phase 1 study in severe bacterial infections and sepsis

Atox Bio completes AB103 phase 1 study in severe bacterial infections and sepsis

Amira to present AM152 preclinical data in fibrotic disease at ATS Annual Meeting

Amira to present AM152 preclinical data in fibrotic disease at ATS Annual Meeting

Tosedostat and OPAXIO study results to be presented at ASCO Annual Meeting

Tosedostat and OPAXIO study results to be presented at ASCO Annual Meeting

GSK, NanoBio initiate two NB-001 Phase 3 trials in cold sores

GSK, NanoBio initiate two NB-001 Phase 3 trials in cold sores

Santaris Pharma advances SPC4955 into Phase 1 trial for high cholesterol treatment

Santaris Pharma advances SPC4955 into Phase 1 trial for high cholesterol treatment

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

Symphogen to present second-generation Sympress platform at ESACT conference

Symphogen to present second-generation Sympress platform at ESACT conference

TSA, Psyadon Pharmaceuticals partner for ecopipam clinical trial in Tourette Syndrome

TSA, Psyadon Pharmaceuticals partner for ecopipam clinical trial in Tourette Syndrome

Impax Pharmaceuticals initiates IPX159 Phase I study in Restless Legs Syndrome

Impax Pharmaceuticals initiates IPX159 Phase I study in Restless Legs Syndrome

GATTEX Phase 3 study results in adult short bowel syndrome presented at DDW 2011

GATTEX Phase 3 study results in adult short bowel syndrome presented at DDW 2011

Two DIFICID Phase 3 trial data in C. difficile presented at DDW conference

Two DIFICID Phase 3 trial data in C. difficile presented at DDW conference

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.